BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 1295468)

  • 41. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
    Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Papillary thyroid carcinoma and related thyroid neoplastic lesions: a light microscopic study with emphasis on nuclear changes.
    Mai KT; Yazdi HM; Perkins DG; Commons AS; Thomas J
    Tumori; 2000; 86(3):238-49. PubMed ID: 10939606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Needle aspiration of 310 thyroid lesions.
    Friedman M; Shimaoka K; Getaz P
    Acta Cytol; 1979; 23(3):194-203. PubMed ID: 294055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathology of some carcinomatous and pseudocarcinomatous aspects of the thyroid.
    Taşcă C; Stefăneanu L
    Morphol Embryol (Bucur); 1976; 22(2):91-7. PubMed ID: 134267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic utility of DNA content flow cytometry in follicular neoplasms of the thyroid.
    Harlow SP; Duda RB; Bauer KD
    J Surg Oncol; 1992 May; 50(1):1-6. PubMed ID: 1573886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow cytometric DNA measurements in human thyroid tumors.
    Christov K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):255-63. PubMed ID: 2874658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].
    Suissa J; Hoang C; Soubrane C; Chigot JP; Khayat D; Leenhardt L; Aurengo A; Turpin G; Le Charpentier Y
    Presse Med; 1994 Feb; 23(4):159-63. PubMed ID: 8177857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study of DNA cytometry methods for benign and malignant thyroid tissue.
    Hostetter AL; Hrafnkelsson J; Wingren SO; Enestrom S; Nordenskjöld B
    Am J Clin Pathol; 1988 Jun; 89(6):760-3. PubMed ID: 3369367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue.
    Campo E; Merino MJ; Liotta L; Neumann R; Stetler-Stevenson W
    Hum Pathol; 1992 Dec; 23(12):1395-401. PubMed ID: 1468777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytopathology of follicular lesions of the thyroid gland.
    Kini SR; Miller JM; Hamburger JI; Smith-Purslow MJ
    Diagn Cytopathol; 1985; 1(2):123-32. PubMed ID: 3841772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Ki-67 as a proliferative marker in lesions of thyroid.
    Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
    Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA aneuploidy in follicular thyroid neoplasia.
    Cusick EL; Ewen SW; Krukowski ZH; Matheson NA
    Br J Surg; 1991 Jan; 78(1):94-6. PubMed ID: 1998875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid.
    Johannessen JV; Sobrinho-Simões M; Lindmo T; Tangen KO
    Am J Clin Pathol; 1982 Jan; 77(1):20-5. PubMed ID: 7055095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroglobulin suppresses thyroid-specific gene expression in cultures of normal but not neoplastic human thyroid follicular cells.
    Ishido Y; Yamazaki K; Kammori M; Sugishita Y; Luo Y; Yamada E; Yamada T; Sellitti DF; Suzuki K
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E694-702. PubMed ID: 24433000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of peroxisome proliferator-activated receptor-gamma expression in benign and malignant thyroid pathologies.
    Karger S; Berger K; Eszlinger M; Tannapfel A; Dralle H; Paschke R; Führer D
    Thyroid; 2005 Sep; 15(9):997-1003. PubMed ID: 16187907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions.
    He X; Wei Q; Zhang X; Xiao J; Jin X; Zhu Y; Cui B; Ning G
    Pathol Res Pract; 2010 Oct; 206(10):712-5. PubMed ID: 20646838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presence of endothelin-1 in the normal and pathological human thyroid.
    Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
    J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histopathologic study of the so called 'palpation thyroiditis'.
    Hwang TS; Park SH
    J Korean Med Sci; 1988 Mar; 3(1):27-9. PubMed ID: 3079564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereology and flow-cytometry of well-differentiated follicular neoplasms of the thyroid gland.
    Mattfeldt T; Schürmann G; Feichter G
    Virchows Arch A Pathol Anat Histopathol; 1987; 410(5):433-41. PubMed ID: 3103324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Punctate cytology of benign and malignant changes in the thyroid gland (author's transl)].
    Krisch K; Jakesz R; Erd W; Klement MB; Feigl W; Sinzinger H; Laczkovics A
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1383-6. PubMed ID: 825740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.